Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

HHS phases out mRNA vaccine trials for COVID-19, bird flu - Roll Call

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine priorities.

Roll Call

What is the mRNA vaccine and why is the US withdrawing funding?

The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other viruses

Evening Standard

RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies'

The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects pharmaceutical giants like Pfizer Inc. (NYSE:PFE) and Moderna Inc. (NASDAQ:MRNA).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

RFK Jr announces halt to $500 million in federal vaccine development funding

US Health Secretary Robert F. Kennedy Jr says the administration is focusing on coming up with a universal vaccine, replacing mRNA technologies and overcoming their limitations.

Euronews

RFK Jr’s health department to halt $500m in mRNA vaccine research

Agency to end 22 federal contracts, questioning safety of technology credited with helping end Covid pandemic

The Guardian - US

US Axes MRNA Vaccine Contracts, Casting Safety Doubts

President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives.

International Business Times

RFK Jr pulls funding for vaccine development

IN FULL

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

RFK Jr cancels $500M in vaccine development after ‘listening to the experts’

HHS announced Tuesday it would start winding down its vaccine development projects that use mRNA technology

The Independent UK

Could we one day get vaccinated against the gastro bug norovirus? Here’s where scientists are at

Norovirus is the leading cause of acute gastroenteritis outbreaks worldwide. It’s responsible for roughly one in every five cases of gastro annually.

The Conversation

Covid cases rising in US as officials plan to restrict booster vaccines

Risks of a wave are compounded by new vaccine restrictions from the Trump administration

The Guardian - US

The world nearly beat polio. Here’s what got in the way

Fake immunisation records, an imperfect vaccine, and leadership missteps have enabled polio’s comeback, an investigation found.

Euronews

Vaccine plea to pregnant women as deadly virus surges

IN FULL

The Independent UK

Takeaways from AP's report on problems in the worldwide campaign to eradicate polio

The World Health Organization has closed in on its bold goal of eradicating polio several times, but the paralytic virus is entrenched in parts of Afghanistan and Pakistan

The Independent UK

The world nearly beat polio. But fake records, an imperfect vaccine and missteps aided its comeback

The World Health Organization has closed in on its bold goal of eradicating polio several times, but the paralytic virus is entrenched in parts of Afghanistan and Pakistan

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Reason

Upholding a Vaccine Mandate, the 9th Circuit Embraces an Alarmingly Broad Definition of 'Public Health'

The appeals court held that the government may require COVID-19 shots based purely on the benefits to recipients.

The Conversation

Vaccine hesitancy: How social and technological issues converged to spawn mistrust

The rise in vaccine-preventable diseases around the world is threatening decades of progress in public health and putting millions of people at risk.

Benzinga

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech SE (NASDAQ:BNTX) reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus loss of $2.42 per share.

The Independent UK

Free STI vaccines now being offered across England

IN FULL

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Foot-and-mouth disease would devastate Australia’s graziers if it got in. Here’s how a new vaccine might help

It sounds innocuous. But foot-and-mouth disease is one of the world’s most economically devastating diseases affecting livestock.

The Independent UK

World-first gonorrhoea vaccine rolled out across UK amid record levels of infection

Antibiotic-resistant strains of the infection are on the rise

Evening Standard

Gonorrhoea vaccine becomes available at sexual health clinics in England

The programme is targeted to those most at risk and could prevent up to 100,000 cases.

The Independent UK

AMA and other medical associations are kicked out of CDC vaccine workgroups

U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer help establish vaccination recommendations

Benzinga

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Shares of Novavax Inc (NASDAQ:NVAX) are trading lower Friday morning, appearing to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna Inc (NASDAQ:MRNA) reported disappointing second-quarter financial results and cut its full-year forecast.

The Conversation

Shingles vaccination rates rose during the COVID-19 pandemic, but major gaps remain for underserved groups

Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That’s the key finding from a new study my colleagues and I published in the journal Vaccine.

Benzinga

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.

1 … 28 29 30 31

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Department of Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.